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There were 83 articles published in the Journal of Cardiovascular Magnetic Resonance (JCMR) in 2011, which is an
11% increase in the number of articles since 2010. The quality of the submissions continues to increase. The editors
had been delighted with the 2010 JCMR Impact Factor of 4.33, although this fell modestly to 3.72 for 2011. The
impact factor undergoes natural variation according to citation rates of papers in the 2 years following publication,
and is significantly influenced by highly cited papers such as official reports. However, we remain very pleased with
the progress of the journal's impact over the last 5 years. Our acceptance rate is approximately 25%, and has been
falling as the number of articles being submitted has been increasing. In accordance with Open-Access publishing,
the JCMR articles go on-line as they are accepted with no collating of the articles into sections or special thematic
issues. For this reason, the Editors feel it is useful to summarize the papers for the readership into broad areas of
interest or theme, which we feel would be useful, so that areas of interest from the previous year can be reviewed
in a single article in relation to each other and other recent JCMR articles [1]. The papers are presented in broad
themes and set in context with related literature and previously published JCMR papers to guide continuity of
thought in the journal. We hope that you find the open-access system increases wider reading and citation of your
papers, and that you will continue to send your quality manuscripts to JCMR for publication.Cardiac volumes, function and mass
CMR is reasonably mature for assessment of cardiac func-
tion, with categorization by age decile, gender and body
surface area for normal values for the left ventricle (LV)
[2], right ventricle (RV) [3] and left atrium [4]. Although
values for special groups are still being defined [5,6], a
number of research papers are still being published for as-
sessment of less common parameters of cardiac perform-
ance [7-9] as well as analysis software [10,11].
Effect of lifestyle intervention plus rosiglitazone or placebo
therapy on left ventricular mass assessed with cardiovascular
magnetic resonance in the metabolic syndrome
Patients with the metabolic syndrome are often found to
have left ventricular hypertrophy and raised LV mass [12].
Thiazolidinediones (rosiglitazone, pioglitazone and trogli-
tazone) represent a group of insulin sensitizing agents
which lower blood glucose levels by enhancing hepatic* Correspondence: d.pennell@ic.ac.uk
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reproduction in any medium, provided the orand peripheral glucose uptake as well as increasing free
fatty acid uptake and storage in adipose tissue (thereby de-
creasing free fatty acid uptake in other tissues) [13].
Whether thiazolidinediones have a beneficial or adverse
effect on LV mass has previously proved controversial.
Roes reported the cardiovascular findings in a randomly
chosen subset of patients involved in a much larger
double-blind randomised controlled trial [14]. This was a
trial looking at lifestyle intervention in combination with
either rosiglitazone or placebo and its effect on carotid ar-
tery atherosclerosis in the metabolic syndrome. Lifestyle
intervention resulted in a reduction of indexed LV mass in
the placebo group, indicating reverse remodelling but
there was no reduction in the rosiglitazone group and the
authors suggest that rosiglitazone therapy may have inhib-
ited this positive reverse remodelling.
Strong cardiovascular prognostic implication of quantitative
left atrial contractile function assessed by cardiac magnetic
resonance imaging in patients with chronic hypertension
Increased left atrial size is a marker of left ventricular
diastolic dysfunction and is a direct result of raised leftLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tic predictor of outcomes in patients with diastolic dys-
function but less is known about the prognostic
significance of atrial contractile function. Over a median
follow-up period of 19 months, Kaminski studied 210
patients with chronic hypertension who underwent a
clinically indicated CMR scan for assessment of left ven-
tricular function, myocardial ischemia or viability [15].
Left atrial contractile function was calculated from
indexed biplane area-length measurements. The active
component of atrial contractile function showed strong in-
dependent associations with major adverse cardiac events
(MACE) (p < 0.0004), all-cause mortality (p < 0.0004), and
non-fatal events (p < 0.0004) even after adjusting for
age, gender, left atrial volume, and LV ejection frac-
tion. This study adds strength to the growing lite-
rature on the prognostic value of CMR-derived
cardiovascular parameters.
Comparison of long and short axis quantification of left
ventricular volume parameters by cardiovascular
magnetic resonance, an ex-vivo validation
It is without doubt that one of the major advantages of
CMR over other imaging techniques is the robust meas-
urement of myocardial volumes and mass. High inter-
study and interobserver reproducibility makes the
technique ideally suited for longitudinal follow-up and
can dramatically reduce sample size required for clinical
trials [16]. Childs reported a comparison of short-axis
derived ventricular volumes versus a novel technique
using six radial long-axis steady state free precession
(SSFP) cine sequences in explanted canine hearts and in
46 patients referred for CMR assessment [17]. Both
short axis and long axis techniques were highly accurate
but the rotational long axis approach proved more
reproducible and time-efficient (with a 27% shorter
evaluation time for experienced operators). A rotational
long axis approach may therefore be a viable alternative
for the clinical assessment of cardiac volumes, function
and mass but would require a redesign of most of the
current commercially available CMR analysis packages.
Regional myocardial function after intracoronary bone
marrow cell injection in reperfused anterior wall infarction
– a cardiovascular magnetic resonance tagging study
This paper was a report of the CMR tagging substudy of
the Autologous Stem Cell Transplantation in Acute
Myocardial Infarction trial (ASTAMI), exploring the re-
generative effects of intracoronary delivery of autologous
mononuclear bone marrow stem cells [18]. Grid tagging
using a FLASH gradient echo sequence was performed
at 2-3 weeks and at 6 months after successful revascu-
larisation with primary percutaneous intervention in
15 patients and 13 controls presenting with anteriorST-segment elevation myocardial infarction. The authors
found an improvement in global and infarct zone strain
in the control group which was greater than that
observed in those who had received intracoronary stem
cells. Conversely, LV mass decreased more in the control
group than the stem cell group. Although the finding
that this type of stem cell therapy does not strengthen
regional or global myocardial function might seem
somewhat disappointing at first glance, investigators in
this field are focused on working out the correct stem
cells to give and the optimal route of delivery. CMR will
be at the forefront of that discovery.
The relative atrial volume ratio and late gadolinium
enhancement provide additive information to
differentiate constrictive pericarditis from restrictive
cardiomyopathy
The differentiation of restrictive cardiomyopathy from
pericardial constriction can be challenging as both con-
ditions may have similar imaging features but require
a very different management strategy. Patients with
surgically documented pericardial constriction (n-23),
restrictive cardiomyopathy (n = 22) and normal subjects
(n = 25) were included in this study [19]. Cheng et al.
compared left and right atrial volumes using a relative
atrial volume ratio (RAR) defined as the LA volume
divided by the RA volume. Using a cut-off value of 1.32
for the RAR, the sensitivity for the detection of constric-
tion was 82.6%, with a specificity of 86.4%. Septal
bounce was identified in 95.7% of constriction patients
but in none of the patients with restriction or the nor-
mal subjects. Late gadolinium enhancement was pre-
sent in 31.8% of those with restrictive cardiomyopathy
but absent in all constriction patients and normals.
Non-invasive techniques such as CMR often rely on
indirect findings and the potential development of ro-
bust diagnostic criteria with the ability to distinguish
constriction from restriction is very welcome for the
practicing clinician.
Cardiovascular magnetic resonance myocardial feature
tracking detects quantitative wall motion during
dobutamine stress
CMR myocardial feature tracking is a new technique
which attempts to track myocardial motion at voxel level
from standard steady-state-free-precession cine acquisi-
tions. The technique generates values for circumferential
and radial strain, and is not currently validated or in
clinical use. Schuster et al performed feature tracking on
10 normals at 1.5 T using the 4 chamber view [20].
Studies were performed at rest and during dobutamine
stress. Strain was measurable in all patients and at rest
and stress. Values increased significantly with dobuta-
mine in parallel with the increase in ejection fraction.
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strain. The authors conclude that feature tracking may
develop into a useful clinical tool with further develop-
ment and validation.Right ventricular dysfunction is a predictor of non-response
and clinical outcome following cardiac resynchronization
therapy
Cardiac resynchronization therapy (CRT) is of proven
benefit in advanced heart failure, but an important sub-
set do not respond. CMR has been increasingly used to
study patients requiring CRT [21]. Alpendurada et al.
studied the incremental significance of right ventricular
function in predicting benefit from CRT in 60 patients
[22]. In a multivariate model, only RV ejection fraction
and myocardial scar burden were significant predictors
of response to CRT. Patients with RV EF < 30% had a
particularly poor response rate (18.2%). The authors sug-
gest that RV function should be measured in patients
being evaluated for CRT.Flow evaluation and valve disease
The capability of CMR to measure cardiovascular flow
contributes greatly to the versatility of CMR in clinical
practice, and development of baseline flow corrections
[23], and automated analysis software [24] continues.
This has greatest application in valve disease [25-27] but
it is also often used in disease of the aorta [28,29], lungs,
coronaries and in congenital heart disease.Cardiovascular magnetic resonance for the assessment
of patients undergoing transcatheter aortic valve
implantation: a pilot study
Correlation and agreement between transthoracic echo-
cardiography (TTE) and CMR in the assessment of aor-
tic root dimension and LV morphology and function
were studied in 49 patients undergoing transcatheter
aortic valve implantation (TAVI) [30]. There was a good
correlation between TTE and CMR in terms of annulus
size (R2 = 0.48, p < 0.001), left ventricular outflow tract
(LVOT) diameter (R2 = 0.62, p < 0.001) and left ventricu-
lar ejection fraction (LVEF) (R2 = 0.47, p < 0.001) and a
moderate correlation in terms of aortic valve area (AVA)
(R2 =0.24, p < 0.001). CMR generally tended to report
larger values than TTE for all measurements. Bland-
Altman analysis indicated that the 95% limits of agree-
ment between TTE and CMR ranged from -5.6 mm to
+ 1.0 mm for annulus size, from -0.45 mm to + 0.25 mm
for LVOT, from -0.45 mm2 to + 0.25 mm2 for AVA and
from -29.2% to 13.2% for LVEF. CMR represents a viable
complementary imaging method to TTE in elderly
patients being considered for TAVI.Pseudoaneurysm of the left ventricle following apical
approach TAVI
This is an interesting case report of a pseudoaneurysm
of the left ventricle following trans-apical TAVI
approach in an elderly lady with severe aortic stenosis
[31]. A 23 mm Edwards Scientific Sapien XT valve
prosthesis (a bovine tissue valve inserted on a cobalt
chromium frame) was implanted with immediate tran-
soephageal echocardiography and fluoroscopic imaging
demonstrated excellent seating of the valve, subsequently
confirmed angiographically. Two days later the patient
developed isolated electrocardiographic evidence of peri-
carditis with minimal associated chest pain. Transthoracic
echocardiography demonstrated a well seated aortic pros-
thesis and a 0.8 cm pericardial effusion with no tam-
ponade. The effusion was not drained and her electrocar-
diographic changes settled over the next few days. Three
months later, transthoracic echocardiography showed a
discrete pseudoaneurysm with late gadolinium myocardial
enhancement. She was managed conservatively with regu-
lar surveillance.
Contrast-enhanced CMR in patients after percutaneous
closure of the left atrial appendage: A pilot study
There are currently a number of commercially available
devices for left atrial appendage (LAA) closure to pre-
vent the formation of thrombus and risk of stroke in
atrial fibrillation. However, imperfect device placement
or suboptimal ‘fit’ causing a residual ‘leak’ into the LAA
has the potential to allow thrombus to form. This would
mandate that the patient remains on long-term anticoa-
gulation medication, thereby negating the potential
benefit from device implantation. Mohrs’ pilot study
of 7 patients with three different device occluders
(Watchman, PLAATO and ACP) assessed the feasibility
of using CMR to detect residual leaks around the devices
[32]. First-pass perfusion using SSFP was followed by a
3D Turbo-FLASH sequence. The authors found a very
high percentage with residual leaks (57%) but noted that
the study only included patients in whom problems of
device malposition or residual leaks were suspected.
There are still questions to be answered (including
whether CMR is able to detect small thrombi on the
device surface) but this very interesting approach is
likely to inform future device design and procedural
quality control.
Sequence optimization to reduce velocity offsets
in cardiovascular magnetic resonance volume flow
quantification - A multi-vendor study
This manuscript describes a follow-up study to the
multi-vendor, multi-centre study by Gatehouse in which
they measured offsets in phase contrast velocity map-
ping studies [33]. In this paper, the effects on velocity
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examined, with the goal of finding a method to minimise
offsets at the acquisition stage without the need of post-
processing correction schemes [34]. Although important,
the conclusion was perhaps overly negative in stating
that with current systems there was no generic protocol
which resulted in acceptable flow offset values.
Congenital and pediatric heart disease
Congenital heart disease remains a major indication for
CMR, and makes particular contribution in the assess-
ment of the major vessels [35], shunt assessment [36], in
complex anatomy, and increasingly in children and neo-
nates [37]. A wide range of clinical scenarios in congeni-
tal heart disease were covered in JCMR in 2011.
Cardiovascular magnetic resonance tagging of the right
ventricular free wall for the assessment of long axis
myocardial function in congenital heart disease
Quantification of right ventricular myocardial function
and any changes of it over time are important issues in
congenital heart disease. Volumetric calculation of right
ventricular (RV) ejection fraction is time consuming to
acquire and analyse, and inter-study reproducibility is
suboptimal. In this study, a linear tag orientated perpen-
dicular to the basal free wall of the RV was used to
measure long axis systolic displacement [38]. The
method was quick to acquire and analyse, reproducible
and showed more significant differences between the
clinical groups studied than did RV ejection fraction.
This suggests it has potential as an additional method,
particularly for longitudinal comparisons.
3D Echo systematically underestimates right ventricular
volumes compared to cardiovascular magnetic resonance
in adult congenital heart disease patients with moderate
or severe RV dilatation
Three dimensional echo is a relatively new technique
which promises to offer a rapid alternative to CMR for
the examination of the right heart. In this study, com-
parison of 3D echo with CMR measurements of RV
volumes and function was undertaken in patients with
varying degrees of RV dysfunction resulting from con-
genital heart disease [39]. The echo technique was found
to underestimate RV volumes significantly, especially in
patients with more severe dilatation and dysfunction.
This lead the authors to conclude that 3D echo, as
implemented, was not ready for routine clinical use for
the assessment of more than mild dilatation of the RV.
Assessment of pulmonary veins after atrio-pericardial
anastomosis by cardiovascular magnetic resonance
Surgical anastomoses of pulmonary veins are prone to
re-stenosis, especially if attempted in the small, delicateveins of infants. For this reason, atrio-pericardial anasto-
mosis uses a pericardial pouch to create a large commu-
nication between the left atrium and the pulmonary
veins. It avoids direct suturing of the pulmonary veins
during the repair of various congenital malformations.
This study reviewed CMR assessments of this approach,
performed in 31 of the 103 patients undergoing the pro-
cedure [40]. Findings were compared with those by
echocardiography, concluding that CMR gave a more
thorough assessment. Even after the atrio-pericardial
anastomotic technique, stenosis of the pulmonary veins
remained a common complication, being identified in 12
of the 31 CMR studies performed.
The role of cardiovascular magnetic resonance in
candidates for fontan operation: proposal of a new
algorithm
Fontan surgery, performed for children with only one ef-
fective ventricle, involves reconnection of the systemic
venous returns to the pulmonary arteries so that the one
effective pump delivers flow to the systemic and then
the pulmonary vasculature in series. The procedure
requires careful pre-operative planning. After revie-
wing the investigations performed and their findings
in 44 patients undergoing Fontan surgery, the authors
of this paper propose a pre-procedure investigative-
diagnostic algorithm [41]. They found that a combi-
nation of trans-thoracic echocardiographic and CMR
investigations can be used to triage patients, some of
whom can then proceed to surgery without the need
for cardiac catheterisation.
The role of cardiovascular magnetic resonance in pediatric
congenital heart disease
CMR is rapidly coming to be regarded as an indispen-
sible imaging and investigative modality in paediatric
cardiology. However, imaging small children with con-
genital heart disease is challenging. This paper provides
an authoritative and clearly written review of the tech-
nical adjustments, imaging protocols and applications of
CMR in the paediatric population [42].
Delayed onset of tricuspid valve flow in repaired
tetralogy of Fallot: an additional mechanism of diastolic
dysfunction and interventricular dyssynchrony
Those who routinely image patients with dilated and/or
pressure loaded RVs are likely to have noticed signs of
prolonged systole of the RV relative to that of the LV.
This study used phase contrast velocity mapping to rec-
ord the time course of tricuspid and mitral flow in 31
children with repaired tetralogy of Fallot [43]. The
authors found delayed onset of tricuspid flow to be com-
mon in this group and associated with reduced RV ejec-
tion fraction. This manifestation of interventricular
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isms of ventricular diastolic dysfunction.
Quantitative cardiovascular magnetic resonance in pregnant
women: cross-sectional analysis of physiological parameters
throughout pregnancy and the impact of the supine position
CMR study of an expectant mother’s haemodynamics is
feasible and acceptable during mid to late pregnancy. It
may be more comfortable in a left lateral than the supine
position. This study of healthy pregnant women, 6 in
mid pregnancy and 8 late in pregnancy, compared
haemodynamic parameters and the effects of position on
them [44]. It concluded that, from as early as 20 weeks,
the left lateral position appears to be preferable. This
was based on the greater stroke volumes and cardiac
outputs measured in this position than supine, which
presumably tends to put pressure on systemic veins
from the lower body.
Comparison between cardiovascular magnetic resonance
and transthoracic Doppler echocardiography for the
estimation of effective orifice area in aortic stenosis
This study compared CMR and echocardiographic
approaches to assessments of aortic stenosis (AS) using
the continuity approach that incorporates calculations of
volume flow at left ventricular outflow tract (LVOT) level,
and the post stenotic jet velocity time integral [45]. CMR
showed the LVOT cross-section to be ovoid, not circular,
and that Echo, which typically recorded the smaller ovoid
diameter, tended to underestimate this area. On the con-
trary, CMR tended to underestimate jet velocities relative
to echo. These presumed errors tended to cancel out,
resulting in little mean difference between the echo and
CMR calculations of effective orifice area. However, CMR
was associated with less intra- and inter- observer variabil-
ity of measurement. Some readers may prefer to measure
stenotic orifice area directly by planimetry from one of a
stack of appropriately acquired CMR cines, aligned to
transect the jet near its origin. This relatively straightfor-
ward approach was not investigated in the study reported.
Pulmonary flow profile and distensibility following acute
pulmonary embolism
This study used phase contrast CMR to record pulmon-
ary artery flow in groups of patients with and without
pulmonary embolus detected by computed tomography
(CT) about 6 months previously [46]. Both groups had
been investigated for suspicion of PE. The sample sizes
were relatively small and the CMR measures followed
the initial months of therapy. Although RV functional
differences had been documented by initial CT, no sig-
nificant differences were found in the amounts or the
temporal profiles of pulmonary flow by the CMR stud-
ies. It remains unclear whether the lack of differencedepended on the time interval and the therapy given.
Only one of the patients had evidence of pulmonary
hypertension at the time of CMR, which recorded the
characteristic notch or depression in mid systolic flow
and a reduction of peak velocity that are expected with
elevated pulmonary vascular resistance.
Repaired tetralogy of Fallot: the roles of cardiovascular
magnetic resonance in evaluating pathophysiology
and for pulmonary valve replacement decision support
Tetralogy of Fallot is one of the commonest and most
important congenital heart conditions whose management
after surgical repair calls for serial follow up by CMR. The
author gives a comprehensive and thoughtful review of
the methods and interpretation of CMR studies in relation
to the pathophysiology of condition [47]. This review is
recommended for reference and for explanations of meth-
ods and measurements that are currently considered to
contribute most to clinical decision making.
Comprehensive 4D velocity mapping of the heart and great
vessels by cardiovascular magnetic resonance
Four dimensional (4D) phase contrast velocity mapping is
a relatively novel and impressive CMR technique. It entails
the acquisition of all 3 directional components of velocity
for voxels distributed in all 3 dimensions of space, trig-
gered over many heart cycles to represent multiple phases
of the cardiac cycle. This paper reviews and illustrates the
methods used for the acquisition, visualization, and quan-
tification of 4D velocity datasets, which typically takes ten
or more minutes [48]. Although more rapid and user-
friendly strategies for acquisition and analysis may be
needed before 4D velocity acquisitions come to be
adopted in routine clinical CMR, their capacity to measure
multidirectional flows throughout a study volume has
contributed novel insights into cardiovascular fluid
dynamics in health and disease.
Cardiovascular magnetic resonance findings in repaired
anomalous left coronary artery to pulmonary artery
connection (ALCAPA)
Secinaro reported the use of CMR in a series of 6
patients at Great Ormond Street Hospital, London with
clinical suspicion of ischemia following surgical repair
for anomalous left coronary artery to pulmonary artery
connection (ALCAPA) [49]. The mean age was 15.3 ±
4.2 years and half were female. Their protocol included
volumes and function, late gadolinium, adenosine stress
perfusion and 3D whole heart acquisition to assess cor-
onary artery origins. In this cohort, basal anterolateral
subendocardial myocardial fibrosis was a characteristic
finding. Stress perfusion identifed reversible ischemia in
3 patients which was indicative of left coronary artery
occlusion, confirmed at coronary angiography in all 3.
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Iron overload cardiomyopathy
Since the first data on myocardial T2* CMR published
in 2001 [50], there has been substantial and rapid pro-
gress in the use of this technique for patient benefit,
with direct calibration to myocardial iron concentration
[51], the association of myocardial T2* < 10 ms with ad-
verse cardiac outcomes [52], and a reduction in cardiac
mortality [53]. These 5 JCMR papers in 2011 continue
to define the role of T2* in multiply transfused patients.
On improvement in ejection fraction with iron chelation
in thalassemia major and the risk of future heart failure
This paper analyzes the importance of increases in ejec-
tion fraction during treatment with iron chelators for
myocardial siderosis on the future likelihood of develop-
ing heart failure, which is the most dangerous complica-
tion of multiple transfusions as the historical mortality is
high once heart failure develops [54]. The premise be-
hind the analysis is that both the absolute level and the
trajectory of ejection fraction are useful markers of heart
failure risk. A UK database was analyzed for patients
with at least two CMR scans (with T2* and ejection frac-
tion) with follow-up for development of heart failure. A
total of 315 patients were included in the analysis, and
patients were stratified into normal or reduced baseline
ejection fraction. Statistical modelling showed that an
improvement in ejection fraction was associated with a
significantly lower risk of developing heart failure irre-
spective of baseline ejection fraction. However, the abso-
lute risk of developing heart failure was greater in
patients with lower ejection fraction. Using data on ejec-
tion fraction change from randomized controlled trials,
the authors showed that the ejection fraction changes
seen with oral deferiprone were associated with a 25.5%
to 46.4% reduction in risk of developing heart failure.
This is important because other iron chelators are not
associated with such increases in ejection fraction des-
pite improving myocardial T2*. The authors suggest that
this difference between the iron chelators might be
explained by the preferential relief by deferiprone of
iron-related mitochondrial dysfunction.
Value of black blood T2* cardiovascular magnetic
resonance
The CMR sequence used to measure myocardial T2* has
gone incremental improvement since the first use of a
non-breathold sequence which was influenced by tissue
T1 in 2001. A single breathold multi-echo sequence was
introduced in 2003 and was shown to be reliable and re-
producible [55]. However, these white blood sequences
were subject to artefactual signal from the white bloodpool smeared in the phase encode direction. This was
problematic in hearts with heavy iron loading and at the
longer echo times. He et al introduced the dark blood
T2* sequence in 2007 [56] and in this paper Smith com-
pares the white and black blood sequences [57]. The
authors show that the black blood sequence had signifi-
cantly improved intra-observer, inter-observer, and inter-
study reproducibility. In addition, the black blood se-
quence has fewer imaging artefacts. Therefore, this se-
quence is recommended for clinical use.
Low prevalence of fibrosis in thalassemia major assessed
by late gadolinium enhancement cardiovascular magnetic
resonance
Post-mortem reports in the 1960s and 1970s showed that
patients dying of myocardial siderosis had severe replace-
ment myocardial fibrosis. If this were the case today, it
would be expected that heart failure related to myocardial
siderosis would be irreversible. However, recent studies
with aggressive intravenous iron chelation [58] have shown
that it is possible to survive siderotic heart failure and re-
gain normal cardiac function [59]. Kirk examined 45 thal-
assemia major patient using late gadolinium enhancement
and found only one patient with enhancement [60]. No pa-
tient with a history of heart failure or low ejection fraction
had LGE. The authors conclude that replacement myocar-
dial fibrosis is unusual in the modern era, possibly due to
the influence of increased use of transfusions, lower infec-
tion rates, or increased use of iron chelation treatments.
Effect of deferiprone or deferoxamine on right ventricular
function in thalassemia major patients with myocardial
iron overload
Considerable attention has been paid to the effect of iron
overload on the left ventricle, but little to its effects on the
right ventricle. Recent work has shown normal right ven-
tricular function in thalassemia [61], and its decline with
myocardial iron loading [62]. This paper by Smith shows
the effect of the iron chelators deferiprone and deferoxa-
mine on right ventricular function [63]. Deferiprone
increased right ventricular ejection fraction and reduced
the end-systolic volume. Deferoxamine however, had no ef-
fect on right ventricular volumes or ejection fraction. The
effects of the oral drug deferiprone with significantly super-
ior to those of the injectable deferoxamine, and may con-
tribute to the improved mortality seen with deferiprone.
Iron overload in polytransfused patients without heart
failure is associated with subclinical alterations of systolic
left ventricular function using cardiovascular magnetic
resonance tagging
Although myocardial T2* has been successfully intro-
duced into clinical practice, it is not as available as it
needs to be in lower income countries where thalassemia
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alternative measure to detect myocardial iron [64]. In 10
patients with myocardial T2* < 10 ms, the authors showed
that subclinical alterations in cardiac function of which left
ventricular twist was the earliest to show abnormality and
correlated best with T2*. Although this is of interest, in
clinical practice, myocardial T2* is more specific for side-
rosis and tagging is less available and more complicated to
analyse than myocardial T2*.
Cardiomyopathy
CMR of patients with cardiomyopathy has become a lead-
ing referral over the last 5 years and there has been consid-
erable interaction with cardiovascular geneticists as CMR
offers high fidelity phenotyping [65], that augments genetic
discovery [66]. CMR physicians have also started to work
closely with electrophysiology colleagues to assess
arrhythmic and sudden death risks [67]. Conditions related
to cardiomyopathy [68,69], and rare forms of cardiomyop-
athy [70,71], are being studied and common themes of
myocardial fibrosis development, pattern of deposition,
strain patterns [72] and association with outcomes are
being established [73]. CMR techniques continue to de-
velop [74], most recently the technique of equilibrium T1
mapping after gadolinium to assess the interstitial compart-
ment has become popular [75], although this is not
straightforward and clinical application is not yet estab-
lished. T2 mapping is also being investigated for its utility
[76], and may be useful in combination with late gadolin-
ium enhancement in conditions such as myocarditis [77].
Hypertrophic cardiomyopathy and ultra-endurance
running - two incompatible entities?
Hypertrophic cardiomyopathy (HCM) is often described
as associated with a reduced exercise capacity, perhaps
best demonstrated by a reduced peak VO2. It is also often
considered that in patients with unexplained LV hyper-
trophy, a suboptimal VO2 is a hallmark of HCM rather
than hypertensive disease. This case study reports an
asymptomatic male athlete with 25 years of ultra-
endurance competition, with genetically confirmed HCM
phenotypically manifesting with LVH, a small LV cavity to-
gether with repolarisation abnormalities suggestive of
HCM [78]. The authors speculate that despite documen-
ted asymmetric hypertrophy and focal myocardial fibrosis
in the basal anteroseptal and inferoseptal walls, it is sus-
pected that the athlete is able to run ultra-marathons due
to a compliant LV with normal diastolic and systolic para-
meters, which is able to augment stroke volume.
Increased left ventricular torsion in hypertrophic
cardiomyopathy mutation carriers with normal wall thickness
In concert with major developments in genetic techni-
ques an important group of patients are those that aregene positive and phenotypically negative, particularly in
HCM. What is controversial is determining early mar-
kers of disease before the phenotype has manifested. In
this study of 17 HCM mutation carriers, and normal
wall thickness, using tissue tagging it was observed that
there was increased LV torsion as well as endocardial
circumferential strain and torsion-to-endocardial-cir-
cumferential-shortening ratio, which reflects the trans-
mural distribution in contractile function [79]. Further
work is required to determine if this may offer a poten-
tial therapeutic target.
Myocardial extravascular extracellular volume fraction
measurement by gadolinium cardiovascular magnetic
resonance in humans: slow infusion versus bolus
Detection of interstitial fibrosis is one of the most excit-
ing fields in CMR at present. There is still much contro-
versy over sequence types, and in particular whether
slow infusion carries significant advantage over the more
practical bolus option. In this study of 10 volunteers,
serial Ve measures were compared across the 2 methods
[80]. Importantly, serial measures of Ve did not differ
significantly between the constant infusion and bolus
methods. There is strong correlation of readings to age.
The findings of this work support development of T1
mapping for extracellular volume fraction (ECV) using
the more pragmatic bolus approach that is also likely to
simplify clinical application.
Myocardial T1 and extracellular volume fraction mapping
at 3 Tesla
Late gadolinium enhancement (LGE) has been the
standard of reference for detecting focal myocardial fi-
brosis in clinical however, it relies on the differences in
signal intensity between scarred and adjacent normal
myocardium to generate image contrast. T1 mapping, is
a promising quantitative method for detecting diffuse
myocardial fibrosis. It has potential to provide significant
insights into myocardial function. In this study, after val-
idation of MOLLI sequences at 3 T in Phantoms, the
authors present values for myocardial and blood T1 pre
and post gadolinium contrast at 3 T [81]. At 3 T, post-
gadolinium ECV is stable between 8.5 and 23.5 minutes
after gadolinium injection.
The clinical impact of late gadolinium enhancement
in Takotsubo cardiomyopathy: serial analysis
of cardiovascular magnetic resonance images
Takotsubo cardiomyapthy, also known as a stress-
induced cardiomyopathy, refers to the transient LV
apical ballooning observed after some form of stress that
usually resolves. Part of the diagnosis assumes unob-
structed coronaries. There is controversy over the pres-
ence of fibrosis. In this study, they observe that in 8
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(1.5 and 6 months later), the presence of LGE in the
subacute phase was associated with greater disease se-
verity and more prolonged recovery [82]. These findings,
if supported by larger studies would help stratify what is
increasingly recognised as a heterogenous cohort of
patients and presentations.
Cardiovascular magnetic resonance in wet beriberi
Wet Beriberi is one of four clinical syndromes associated
with Thiamine (Vitamin B1) Deficiency. Wet beriberi
has varying degrees of cardiovascular involvement. In its
most fulminant form, it is characterized by hypotension,
tachycardia and lactic acidosis. If untreated, patients die
within hours from circulatory collapse and pulmona-
ry edema. This condition often goes unrecognized since
it is easily confused with other illnesses. This is the
first report demonstrating the CMR finding of myo-
cardial edema associated with wet beriberi and uses a
T2 mapping technique to gauge quantitative assess-
ment [83]. Whilst an unusual case, it has relevance at
a global level to those who encounter such patients
and shows the application of T2 mapping in myocar-
ditic settings.
Cardiovascular magnetic resonance of cardiomyopathy
in limb girdle muscular dystrophy 2B and 2I
Limb-girdle muscular dystrophy (LGMD) comprises a
group of genetically-heterogeneous disorders that
present with variable skeletal and cardiac muscle in-
volvement. LGMD produces progressive weakness of
proximal shoulder-girdle or pelvic muscles with a wide
range of phenotypic expression, severity, and age of dis-
ease onset. What is less clear is the extent and degree of
cardiac involvement. In this study, consecutive patients
with genetically-proven LGMD types 2I (n = 7) and 2B
(n = 9) and 8 control subjects were enrolled [84]. All
subjects underwent CMR with cine imaging for left ven-
tricular volume and ejection fraction measurement, vec-
tor velocity analysis of cine data to calculate myocardial
strain, and late post-gadolinium enhancement imaging
to assess for myocardial fibrosis. The majority of patients
with LGMD of 2 subtypes - 2B, and 2I - in this cohort
showed normal LV size, global systolic function and peak
systolic circumferential strain. However, there was evi-
dence of subclinical myocardial fibrosis in 57% of sub-
jects with LGMD2I and 33% of subjects with LGMD2B.
This abnormality was accompanied by diastolic dysfunc-
tion in a number of patients. Overall, the prevalence of
advanced cardiomyopathy in patients with LGMD2I and
LGMD2B appears to be limited in this cohort of
patients, but subclinical fibrosis and diastolic dysfunc-
tion do occur and may warrant use of cardioprotective
medical therapies.Late gadolinium enhanced cardiovascular magnetic
resonance of lamin A/C gene mutation related dilated
cardiomyopathy
The lamin A/C gene (LMNA) is so far the most signifi-
cant disease gene identified clinically for dilated cardio-
myopathy (DCM). It has been estimated that LMNA
mutations cause up to 10% of familial DCM. The pene-
trance of the LMNA mutations causing cardiomyopathy
is nearly complete. It is associated with an increased risk
of sudden death and heart-failure. The main aim of this
study was to characterise myocardial fibrosis, regional
wall motion abnormalities, ventricular dilatation, longi-
tudinal LV systolic function and global function with
LGE CMR in asymptomatic or mildly symptomatic car-
riers of LMNA mutations causing DCM [85]. They also
looked at the possible association between the localisa-
tion of myocardial fibrosis and the conduction abnor-
malities documented with electrocardiography. This is a
relatively small study of 17 patients but what was inter-
esting was that 88% had demonstrable myocardial fibro-
sis. Where present, there was an association with
conduction abnormalities. A high proportion also had
mild LV dilatation, impairment in function or longitu-
dinal systolic function. As our genetic capabilities
expand, the close link between genotype and phenotype
is likely to yield interesting and important findings. It
will also be interesting to see the phenotypic manifesta-
tions and subsequent clinical implications of the newly
identified titin mutation that has been identified to
account for about 30% of cases of familial DCM.
Cardiac resynchronization therapy guided by late
gadolinium-enhancement cardiovascular magnetic
resonance
Cardiac resynchronization therapy has become an import-
ant mainstay in the management of patients with heart-
failure. Unfortunately, about 30% of patients do not seem
to show a clinical response. As a relatively expensive form
of treatment, there is a need for better stratification of Pa-
tient selection and also to deploy better methods of opti-
mizing lead placement at the time of implantation. In this
study, the authors assessed whether the use of late gado-
linium enhancement CMR scan to guide deployment of
the LV lead in a non-scarred segment of the LV free wall
leads to a better long-term outcome from CRT than using
a conventional implantation approach [86]. This is a large
study of 559 patients with heart-failure due to both an is-
chaemic related and non-ischaemic basis. Implantations
were either guided (+CMR) or not guided (-CMR) by
LGE-CMR prior to implantation. Fluoroscopy and LGE-
CMR were used to localize the LV lead tip and myocardial
scarring retrospectively. Clinical events were assessed in
three groups: +CMR and pacing scar (+CMR+ S); CMR
and not pacing scar (+CMR-S), and; LV pacing not guided
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imum period of 9 years, the + CMR+ S group had the
highest risk of death from pump-failure and sudden death,
compared to the other cohorts, and lowest in the + CMR-
S group. These findings highlight the potential for CMR
to guide CRT lead deployment but also that pacing
scarred tissue is associated with a much worse outcome –
presumably due to provoking re-entrant arrhythmias.
Cardiovascular magnetic resonance in cardiac sarcoidosis
with MR conditional pacemaker in situ
One of the main challenges confronting CMR is the bur-
geoning number of patients with conventional pace-
makers/devices implanted. Whilst under certain
restricted conditions, some sites are proceeding with
CMR in these patients, and where there is an over-
whelming benefit to risk balance, most sites remain con-
servative in their approach. For this reason, there has
been great interest in MR-conditional devices. In this
interesting case report, Quarta and colleagues describe
how the management of a Patient with sarcoid and such
a device, was facilitated by being able to perform CMR
on the heart and secondly the impact of their findings
[87]. Image quality was excellent and supports the case
that there should be growing use of MR-conditional
devices to ensure we do not preclude patients from de-
riving the benefits of CMR.
Mild hypothermia delays the development of stone heart
from untreated sustained ventricular fibrillation - a
cardiovascular magnetic resonance study
Manoeuvres to improve outcomes following a ventricu-
lar fibrillation (VF) arrest are likely to improve the
current suboptimal outcomes. In this study of 14 swine
randomised to normothermia or hypothermia, the latter
reduced the early LV dilatation typically seen and im-
portantly, delayed the onset of stone heart thereby
extending a known, morphologic limit of resuscitability
[88]. These findings have important implications to algo-
rithms for managing a VF arrest.
T2-weighted cardiovascular magnetic resonance in acute
cardiac disease
This excellent review assesses the impact of T2-weighted
imaging in the assessment of acute cardiac disease [89].
Applications include the assessment of myocardial sal-
vage as well as detection of acute myocarditis. Key
strengths lie in its combination with late enhancement
imaging. Whilst much focus has been on its diagnostic
value, important newer areas are quantifying the area at
risk and providing a quantitative means of assessing dis-
ease burden to determine therapeutic efficacy and gauge
risk. Future work needs to focus on improving sensitiv-
ity, better quantification, timescale of changes, and whatthe true incremental value is for example in ACS in large
well planned outcome studies.
Effects of steroids and angiotensin converting enzyme
inhibition on circumferential strain in boys with Duchenne
muscular dystrophy: a cross-sectional and longitudinal
study utilizing cardiovascular magnetic resonance
Whilst it is well recognised that Duchenne muscular
dystrophy (DMD) carries an increased risk of cardiac
morbidity, treatment of this cohort of patients suffers
from a lack of systematic prospective clinical trials. In
this study, the authors identified patients for inclusion in
one of two treatment groups [90]. Group A was only
treated with corticosteroids (either deflazacort or pred-
nisone). Group B was being treated with corticosteroids
plus ACEi (lisinopril or enalapril) or ARB (losartan). All
patients in Group B had been treated with ACEI/ARB
for a minimum of 12 months prior to CMR, and all
patients in both groups had been treated with corticos-
teroids for at least 12 months prior to CMR. Initiation of
corticosteroids and ACEI/ARB was determined exclu-
sively by treating physician preference and were not
based on CMR results. DMD boys not treated with cor-
ticosteroids or treated with beta blockers were excluded.
Limitations include the lack of randomisation, physician
preference in treatment, retrospective nature and lack
of control. Notwithstanding, in 171 patients – a large
cohort, there was no clear difference in slowing the
decline in cardiac function. It highlights the need for
ongoing work to look at more novel or targeted treat-
ment strategies.
Prevalence and distribution of regional scar
in dysfunctional myocardial segments in Duchenne
muscular dystrophy
Duchenne muscular dystrophy (DMD), is the most com-
mon of the muscular dystrophies. It has an incidence of
1 in 3,500 males. It is an X-linked recessive disorder
resulting from a disabling mutation of the gene encoding
dystrophin, a sarcolemmal protein found in skeletal and
cardiac muscles. There is progressive skeletal muscle
weakness with loss of ambulatory ability in the teenage
years. Death is usually due to cardiac or respiratory fail-
ure, and distinctive pathologic findings have been noted.
As noted by the authors, with improvements in overall
management and respiratory treatment, there has been
increasing focus on the prevention and treatment of car-
diac disease in this condition. In this study, strain using
myocardial tagging and fibrosis patterns were deter-
mined in a cohort of 16 patients with DMD [91]. There
was also correlation with echo assessed segmental strain.
Scar tissue was found to most common in the inferio,
inferolateral and anterolateral walls, although seen in
other regions as well. The relationship between scar and
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with high negative but lower positive predictive for Ecc
in the determining segments with scar.
Presence of mechanical dyssynchrony in Duchenne
muscular dystrophy
As noted above, DMD carries a high morbidity and mor-
tality rate with cardiac dysfunction an important cause.
In this large study of 236 Patients with DMD, dysyn-
chrony was assessed based on timing of CMR derived
circumferential strain (ecc) [92]. The calculated indices
included cross-correlation delay (XCD), uniformity of
strain (US), regional vector of variance (RVV), time to
maximum strain (TTMS) and standard deviation (SD) of
TTMS. Abnormal XCD value was defined as > normal +
2SD. As noted by the authors, there was overall low
prevalence of circumferential dyssynchrony in the entire
DMD population; it increased to 17.1% for patients with
abnormal EF and to 31.2% in the most advanced stage
(abnormal EF with fibrosis). All but one DMD patient
with mechanical dyssynchrony exhibited normal QRS
duration suggesting absence of electrical dyssynchrony.
The calculated US and RVV values (0.91 ± 0.09, 1.34 ±
0.48) indicate disperse rather than clustered dyssyn-
chrony. Patients also had a high prevalence of lateral
wall fibrosis although usually in advanced disease. These
findings suggest that CRT therapy is unlikely to offer
much benefit in this population of patients.
Atheroma and vascular
CMR is well suited to characterising the atherosclerotic
arterial wall. Research has been focussed on early detec-
tion [93,94], pathogenesis [95-97], the monitoring of
response to treatment, and relation to outcomes [98],
rather than stenosis assessment for which other techni-
ques are widely used. Vessel wall CMR, magnetic reson-
ance angiography and other techniques benefit from the
use of 3 T and higher fields [99,100]. The papers in this
section illustrate the variety of ways that CMR can be
used to investigate vascular disease.
Age determination of vessel wall hematoma in spontaneous
cervical artery dissection: A multi-sequence 3 T
cardiovascular magnetic resonance study
This is an elegant prospective observational study in 35
patients with first time spontaneous cervical artery dis-
section to determine the age of vessel wall hematoma
using multiple-weighted CMR on a 3 T scanner [101].
The manuscript is well written and data are well pre-
sented. The mean age of spontaneous cervical artery dis-
section (sCAD) was 2.0, 5.8, 15.7 and 58.7 days in
patients with acute, early subacute, late subacute and
chronic vessel wall hematoma (VWH) as classified by
CMR (p < 0.001 for trend). Agreement was moderatebetween VWH types in this study and the previously
proposed time scheme of signal evolution for cerebral
hemorrhage, Cohen's kappa 0.43 (p < 0.001). There was
a strong agreement of CMR VWH classification com-
pared to the time scheme which was proposed for ca-
rotid intraplaque hematomas with Cohen's kappa of 0.74
(p < 0.001).
Magnetization transfer magnetic resonance of human
atherosclerotic plaques ex vivo detects areas of high
protein density
This study investigates the use of magnetization transfer
contrast (MTC) for atherosclerotic plaque characterization
at 11.7 T [102]. High-resolution (0.047 × 0.047 × 0.5 mm)
ex-vivo MTC MRI of human carotid artery specimens
obtained from endarterctomy was performed. The main
findings are that the magnetization transfer contrast ration
(MTR = [MTCoff - MTCon]/MTCoff) allows detection of
areas with high protein content and thus discrimination
between thick collagen-I (MTR = 54%) and thin collagen-
III fibers (MTR = 11%) as well as age classification of intra-
plaque hemorrhage (IPH). MTR of acute red cell rich IPH
was 9%, of recent fibrin rich IPH 55% and of old IPH, rich
in protein debris, was 69%. Surprisingly, lipid rich areas
with relatively low protein content had an MTR of 46%.
The authors conclude that MT CMR enhances plaque tis-
sue contrast and identifies the protein-rich regions of
carotid artery specimens. The additional information from
MTR of IPH may provide important insight into the role
of IPH on plaque stability, evolution, and the risk for fu-
ture ischemic events.
Assessment of the kidneys: magnetic resonance
angiography, perfusion and diffusion
This review article addresses renal MRA and advanced
renal MR techniques which is an interesting and import-
ant subject [103]. The current role of contrast agents
and their safe use in patients with renal impairment is
laid out and an insight beyond the current applications
of renal MRA is provided. The clinical value and specific
applications of renal MR are critically discussed. The
author covers the subject well and offers a balanced
appraisal of the techniques and their limitations as well
as highlighting areas of future development. The article
is well illustrated.
Characterization of healing following atherosclerotic
carotid plaque rupture in acutely symptomatic patients:
an exploratory study using in vivo cardiovascular
magnetic resonance
This paper describes the use of lumen curvature mea-
surements obtained from MR images to characterize
healing of ruptured plaque in individuals who have
recently suffered from a transient ischemic attack [104].
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MR images were followed up after 3 and 12 months and
the lumen curvature and roughness estimates were
obtained. In individuals who did not have a follow up
event, the plaque rupture showed signs of healing as
demonstrated by reduction in maximum lumen curva-
ture and improvement is surface roughness. The main
limitations of the study include the small sample size
especially in the group that had follow up events. The
investigators therefore limited their analysis to only
the group that did not have follow up events. Other
limitations include the fact that the robustness and
reproducibility of the approaches used have not been
thoroughly validated.
Carotid plaque regression following 6-month statin
therapy assessed by 3 T cardiovascular magnetic
resonance: comparison with ultrasound intima media
thickness
This study compares CMR and B-mode ultrasound in
monitoring changes in plaque burden over 6 months of
statin therapy [105]. In 26 subjects, of whom 13 had ini-
tiation or increase in statin dosing, they found that
plaque volume as measured by CMR significantly
decreased by 5.8% whereas IMT remained unchanged.
These findings support the concept of volumetric plaque
acquisition as important step in the analysis of an asym-
metric disease. The authors divided axial wall area
into 6 regions and found that wall thickness differed
between regions and the region with smallest wall
thickness showed largest regression. The study is li-
mited by the sample size and the variable statin do-
sing and regimen.
Dilation of the ascending aorta in Turner syndrome - a
prospective cardiovascular magnetic resonance study
This paper reports serial measurements of aortic dimen-
sions in Turner syndrome patients and provides some
insight into the degree of aortic growth and its asso-
ciated risk factors [106]. The authors demonstrated a
small but statistically significant growth rate (0.1 –
0.4 mm/yr) of the proximal aortic segments in the
Turner population during 2.4 year mean follow up. The
rate of growth at the sinus segment is demonstrated to
be greater in those with BAV as opposed to trileaflet aor-
tic valves. The authors conclude that a general aortopa-
thy is present in TS with enlargement of the ascending
aorta, which is accelerated in the presence of a bicuspid
aortic valve.
Magnetic resonance angiography: current status
and future directions
This is an excellent review that covers all aspects of
magnetic resonance angiography in some depth [107].The overall background is good, the references adequate
and the images are of uniformly excellent quality.
Consistency of aortic distensibility and pulse wave velocity
estimates with respect to the Bramwell-Hill theoretical
model: a cardiovascular magnetic resonance study
The authors use a well-known model to derive theoretical
values for aortic pulse wave velocity (PWV) from CMR-
assessed data, and compared these with CMR-assessed
values for PWV in the aortic arch [108]. CMR data was
assessed in 46 healthy volunteers. Aortic stiffness is
expressed in pulse wave velocity (PWV) of the aortic arch,
and distensibility of the ascending aorta (determined by the
local aortic area change and pulse pressure). Pulse pressure
is estimated from a brachial pressure cuff-measurement
and by carotid tonometry. The CMR-derived PWV in the
aortic arch is compared with the theoretical local PWV
(determined from distensibility assessment). The authors
show good correlation between measured and theoretical
PWV (r = 0.78). The paper is well written, the methods ap-
plied are appropriate and validated, although not new and
the conclusions drawn from the results are appropriate.
CMR Assessment of endothelial damage and
angiogenesis in porcine coronary arteries using
gadofosveset
This is a well-written study on the use of an albumin
binding contrast agent for assessment of endothelial in-
tegrity in a pig model of coronary injury [109]. The
authors validated their in-vivo and ex-vivo imaging find-
ings of increased contrast uptake (~30 minutes post
contrast agent injection) in the area of injury by Evan’s
blue dye injection and subsequent histological analysis.
Furthermore, staining for neovessels was performed and
a correlation between neovessel density and ex-vivo con-
trast uptake was found. These are important findings as
endothelial dysfunction is found both in early and late
stages of atherosclerosis while angiogenesis is believed to
be associated with plaque destabilization.
Determination of edema in porcine coronary arteries
by T2 weighted cardiovascular magnetic resonance
Although inflammation plays a key role in the progres-
sion of atherosclerotic plaques, it is the prediction of the
next ‘culprit’ or ‘hot’ lesion with the potential to rupture
giving rise to an acute coronary syndrome which is a
major challenge in patients with coronary artery disease.
Pedersen looked at edema in the proximal left anterior
descending coronary artery in pigs following balloon
injury using T2-weighted short tau inversion recovery
(STIR) and conventional T2-weighted spin echo
sequences [110]. STIR signal was much higher in the
injured segments and detected edema with a sensitivity
of 100% and a specificity of 71% using a threshold value
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signal intensity. This correlated well with histological
findings however, conventional T2-weighted images did
not show significant changes in signal intensity post
injury. This is a promising technique but poses a chal-
lenge in clinical practice due to the limitations of scan-
ning small cross-sectional areas of the coronary artery.
Multimodal cardiovascular magnetic resonance quantifies
regional variation in vascular structure and function
in patients with coronary artery disease: relationships
with coronary disease severity
To date, most of the CMR studies looking at vascular para-
meters have focused on patients presenting with carotid
disease [111,112]. Kylintireas studied 100 patients with
known coronary artery disease, demonstrating atheroma-
tous disease in various locations within the vascular tree
[113]. In a multivariate analysis, carotid atheroma class,
distal descending aorta atheroma burden, aortic distensibil-
ity and brachial artery reactivity correlated modestly with
and were independent predictors of severity and extent of
coronary artery disease, as expressed by the modified
Gensini score. A comprehensive approach to CMR scan-
ning is likely to extend our knowledge and understanding
of the effects of atheroma and vascular disease throughout
the cardiovascular system. This study provides an insight
into which CMR parameters might be of further use with
respect to the design of future clinical trials.
Perfusion
Perfusion CMR has grown into a clinically important
examination and is challenging established referral pat-
terns for nuclear based techniques [114]. New steps in
optimisation continue to be published [115,116] includ-
ing accelerated acquisition, high field CMR, new stress
protocols [117,118], assessment of new treatments
[119,120], and improved analysis including quantifica-
tion [121,122]. Progress in perfusion CMR in children
and women in particular has occurred in a desire to
lower radiation burden in these sensitive individuals.
However there remains room for improvements in ease
of analysis and quantification, artefact elimination,
robustness and relation to outcomes.
Diagnostic accuracy of adenosine stress cardiovascular
magnetic resonance following acute ST-segment
elevation myocardial infarction post primary angioplasty
Adenosine perfusion CMR is well established in chronic
coronary disease, but its role in acute coronary disease is
less well tested especially in the detection of non-culprit
lesion ischemia. Wong et al studied 59 patients 3 days
after acute ST-elevation myocardial infarction with 41%
anterior infarctions and 100 non-culprit vessels [123].
The accuracy of perfusion CMR was 96%, withsensitivity of 99% and specificity of 67%. There was
little diagnostic difference between visual and semi-
quantitative analysis. The results suggest that perfu-
sion CMR is diagnostically useful in the setting of
acute infarction.
Development of a universal dual-bolus injection scheme
for the quantitative assessment of myocardial perfusion
cardiovascular magnetic resonance
The dual bolus protocol for gadolinium injection for
myocardial perfusion CMR enables accurate quantifica-
tion but has disadvantages for complicated set-up. Ishida
et al propose a simpler dual bolus regime which may
have greater clinical utility [124]. The regime was tested
on several MR scanners with different acquisition
sequences, gadolinium compounds and doses, and was
found to work well under these various conditions. The
authors suggest that their regime could be used clinically
obviating the need for complicated set up.
Preliminary assessment of cardiac short term safety
and efficacy of manganese chloride for cardiovascular
magnetic resonance in humans
In contrast to Gadolinium chelates, manganese-
containing agents are intracellular and manganese chlor-
ide is rapidly taken up into myocytes. Fernandes pub-
lished preliminary safety and efficacy data regarding the
use of manganese chloride in 17 healthy volunteers
[125]. A significant reduction in T1 was observed in all
subjects, sustained up to 30 minutes. The infusion was
well tolerated with no major adverse events, however all
patients reported a transient facial flush. This predict-
able, sustained reduction in T1 is described by the
authors as a ‘memory effect’ that can be potentially
explored to develop new imaging strategies.
Acute coronary syndrome
CMR research in acute coronary syndromes has been
stimulated by visualisation of pathological processes that
are difficult [126] or impossible to image by other
in-vivo techniques; This includes microvascular obstruc-
tion, myocardial edema, myocardial salvage, age of
infarction [127] alternative diagnoses [128] and
co-morbidities [129]. Improved techniques [130] and
understanding of the events and their time course after
acute coronary syndromes has potential to improve out-
comes of primary percutaneous coronary intervention.
Myocardial area at risk and salvage measured
by T2-weighted cardiovascular magnetic resonance:
Reproducibility and comparison of two T2-weighted
protocols
The concept of myocardial area at risk and salvage in
acute myocardial infarction is of major interest and key
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reduce infarct size. Lønborg performed a comparison of
two different T2-weighted CMR protocols to assess the
myocardial area at risk and salvage index in 91 patients
with acute ST-elevation myocardial infarction treated
with primary percutaneous coronary intervention [131].
A second scan was performed at 3 months to look at
final infarct size using a standard late gadolinium en-
hancement technique. The two STIR sequences each
used a different slice thickness and echo time, detecting
a statistically significant difference in the extent of myo-
cardial oedema (and hence salvage index). Using a slice
thickness of 15 mm picked up a larger area at risk than
the sequence with a slice thickness of 8 mm (p < 0.01).
Whilst the authors were not able to provide a specific
recommendation for one sequence over the other, this
study underlines the importance of understanding the
specific protocol used for assessment of area at risk and
its potential impact on the results of clinical trials.
Chronic ischemic heart disease
The use of late gadolinium enhancement (LGE) has trans-
formed the investigation and clinical practice of chronic
coronary disease, and recently yielded new insights into
infarction, viability, medical treatment [132] and revascu-
larisation [133]. Work is still progressing on how best to
quantify LGE in relation to outcome, and the relative mer-
its versus dobutamine stress CMR [134]. The JCMR
papers presented examine important aspects of this field.
The role of dobutamine stress cardiovascular magnetic
resonance in the clinical management of patients
with suspected and known coronary artery disease
Dobutamine stress CMR is effective in the identification of
myocardial ischemia, but often in the research setting.
Gebker et al report a large study of 1532 patients to deter-
mine the value of the technique in the routine clinical set-
ting [135]. Patients with positive stress CMR were
recommended to undergo coronary angiography and those
with negative stress CMR received optimal medical therapy.
Of 609 positive patients, 478 (78%) had coronary angiog-
raphy within 90 days and of these 409 (89%) had significant
coronary stenosis. of 923 negative patients, only 8 patients
(0.96%) had a cardiac event during a mean follow-up period
of 2.1 years. In 131 positive patients who did not undergo
coronary angiography, 20 (15%) patients had a cardiac
event. The authors conclude that dobutamine stress CMR
has substantial clinical utility in the general clinic setting.
Prevalence of scarred and dysfunctional myocardium in
patients with heart failure of ischaemic origin: A
cardiovascular magnetic resonance study
Ischaemic heart disease is a common cause of left ven-
tricular systolic dysfunction which can lead to chronicheart failure. The role of revascularisation for potentially
hibernating areas of myocardium remains unclear but
previous studies of heart failure patients with evidence
of significant viability have been neutral in terms of hard
endpoints and have not included late gadolinium CMR
for assessment of viability [136-138]. It is in this context
that Bourantas scanned a cohort of 193 patients with
evidence of ischaemic heart disease and LV ejection frac-
tion < 50% [139]. Myocardial contractility and transmural
extent of scar were assessed using a 17-segment model.
Although approximately half of all myocardial segments
showed contractile dysfunction, only one third of these
had > 50% of the wall thickness affected by scar, sugges-
ting that most could improve in response to an appro-
priate intervention. Further research is required to
determine whether the extent of myocardial scar as mea-
sured by late gadolinium CMR can be used to predict the
likely extent of recovery in ventricular function with
pharmacological interventions and revascularisation.
Value of scar imaging and inotropic reserve combination
for the prediction of segmental and global left ventricular
functional recovery after revascularisation
Previous authors have noted the utility of adding a low-
dose dobutamine stress protocol to conventional scar
imaging in order to improve the potential predictive
value of CMR for assessment of hibernation prior to
revascularisation [140]. Glaveckaite studied the combin-
ation of low dose dobutamine (to assess contractile
reserve) together with transmurality of late gadolinium
enhancement and the thickness of the residual viable
‘rim’ of myocardium in 46 patients with coronary artery
disease before and after revascularisation [141]. Baseline
LV ejection fraction was 35 ± 8%. Receiver operator
curve analysis showed that a combined model of low
dose dobutamine and infarct transmurality gave the
strongest sensitivity and specificity for prediction of im-
provement in LV ejection fraction following revasculari-
sation (area under the curve 0.84, p < 0.001). This paper
adds to the growing weight of literature regarding CMR
assessment of viability and likelihood of functional myo-
cardial recovery after successful revascularisation.
Effect of ischemic preconditioning in skeletal muscle
measured by functional magnetic resonance imaging
Ischaemic preconditioning (both in the myocardium and
in remote organs) has been shown to mitigate ischemia-
perfusion injury, thereby reducing infarct size following
coronary artery occlusion [142,143]. Using a model of leg
ischemia in healthy subjects at 3 T, Andreas compared
31P MR spectroscopy and blood oxygen level dependence
(BOLD) with isometric muscle strength [144]. Ischemic
preconditioning 4 hours prior to a period of ischemia sig-
nificantly increased the maximal phosphocreatine (PCr)
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hyperaemic reperfusion (p < 0.05). This suggests a positive
influence on muscle metabolism during reperfusion with
an increase in PCr production and higher oxygen con-
sumption. Mimicking arterial stenosis with low-flow
reperfusion prevented the recovery of PCr and was asso-
ciated with a decrease in muscular strength, thus high-
lighting the importance of full and rapid reperfusion. This
promising work indicates that functional MR can provide
an objective assessment of changes in muscle metabolism
following reperfusion and therapeutic interventions
in vivo. If this can be reliably extrapolated to the heart, it
could be a valuable tool for assessment of myocardial
ischemia-reperfusion models in patients.
Prevalence and prognosis of myocardial scar in patients
with known or suspected coronary artery disease
and normal wall motion
In contrast to CMR which has a high sensitivity and specifi-
city for detecting myocardial infarction using LGE imaging,
other non-invasive imaging techniques can miss subtle sub-
endocardial infarcts [145]. Krittayaphong takes this one
stage further, looking at 1148 patients with suspected or
known coronary artery disease who had normal left ven-
tricular wall motion [146]. Multivariate analysis was used
to look at the association of a panel of clinical factors, med-
ications prescribed, ECG detection of myocardial infarction
and CMR parameters (presence of late enhancement, LV
volumes and mass) with outcomes. LGEwas detected in
104 patients (9.1%) and over an average follow-up of 955 ±
542 days, the presence of late enhancement was the stron-
gest predictor of outcomes in terms of hard endpoints (car-
diac death and nonfatal myocardial infarction, p = 0.004)
and major adverse cardiac events (p < 0.001). It cannot
therefore be assumed that the absence of a left ventricular
wall motion abnormality excludes underlying structural
heart disease, thereby indicating a good prognosis.
Technical advances and new techniques
The editors of JCMR continue to support publication of
new CMR techniques involving new sequences [147-
149], applications [150-153], animal models [154-156]
and analysis techniques [157]. Recent review articles
have proven very popular [158-160] and we have contin-
ued to commission such articles in new fields. These
new techniques described in this section are of interest
especially to the CMR physics community for translation
into robust new human tools.
Quantitative comparison of myocardial fiber structure
between mice, rabbit, and sheep using diffusion tensor
cardiovascular magnetic resonance
The fundamental understanding of cardiac structure and
function requires structural models of the heart, butlittle is known about interspecies structure variation.
Using diffusion tensor imaging (DTI), which was
recently reviewed in JCMR [161], Healy scanned mouse,
rabbit and sheep hearts after fixation and quantitatively
assessed fiber orientation and the transmural range and
linearity of fiber helix angles [162]. The authors showed
significant differences between species and argue that
caution must be exercised in extrapolating results
between animals.
Comprehensive Cardiovascular magnetic resonance
of myocardial mechanics in mice using three-dimensional
cine DENSE
This paper describes the development and implementa-
tion of a 3D cine DENSE pulse sequence on a 7 T small-
bore scanner for the study of micromechanics in mice
[163]. This highly sophisticated MR technique used
three-point phase cycling for artifact suppression and a
stack-of-spirals k-space trajectory for efficient data ac-
quisition. Using these methods, multiphase normal and
shear strains were measured, as were myocardial twist
and torsion and the resulting 25-min acquisition time
represents a huge improvement over the currently used
2D methods.
Non-triggered quantification of central and peripheral
pulse-wave velocity
This paper represents the latest development in methods
for measurement of arterial pulse wave velocity (PWV)
[164]. The MR sequence is “real-time” and therefore
doesn’t require cardiac triggering so that it can be used
to monitor PWV changes over several cycles. The
method which "simultaneously" excites and collects a
series of velocity-encoded projections at two arterial seg-
ments to estimate the wave-front velocity was used to
study PWV between the aortic arch and iliofemoral ar-
teries in normal subjects. This appears to be the first to
demonstrate variations in PWV between cardiac cycles.
Simultaneous mapping of temporally-resolved blood flow
velocity and oxygenation in femoral artery and vein
during reactive hyperemia
The outcome of the research described in this manuscript
was an integrated study of flow and oxygen saturation for
improved assessment of vascular disease [165]. The
authors describe a method to assess the hyperemic re-
sponse in the femoral artery by measuring changes in both
flow and oxygen concentration by use of a combination of
velocity-encoded projections and multi-echo susceptibility
weighted imaging. It is shown that multiple parameters
may be quantified enabling more detailed assessment of
peripheral vascular reactivity in a single cuff paradigm ra-
ther than in separate procedures as generally required,
thus improving study efficiency and patient comfort.
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encoding at 3 T
Despite a number of advantages a particular problem with
phase contrast velocity mapping of the myocardium is the
long acquisition times. This manuscript describes a study
to assess the impact of using frame-by-frame SENSE to
accelerate the acquisition of such maps and therefore
make them more clinically applicable [166]. The work was
done on a 3 T scanner with a 32 channel receiver coil and
the results show that even with an acceleration factor of 4
there is minimal impact of the measured myocardial vel-
ocities throughout the cardiac cycle.
Regional contrast agent quantification in a mouse model
of myocardial infarction using 3D cardiac T1 mapping
This manuscript describes the application of a recently
developed 3D T1 mapping technique in the mouse to
study myocardial infarction and to measure differences
in myocardial T1 before and after injection of a liposo-
mal contrast agent [167]. This was then used to assess
the concentration of accumulated contrast agent which
was compared and correlated to ex vivo concentrations
determined by ICP-MS. The manuscript represents a
further progression in the development of techniques
available to those wishing to study heart in such models.
Quantification and visualization of cardiovascular 4D velocity
mapping accelerated with parallel imaging or k-t BLAST:
head to head comparison and validation at 1.5 T and 3 T
This manuscript is a validation of quantitative in vivo
cardiac 4D flow measurements where the acquisition
has been accelerated with parallel imaging and k-t
BLAST at 1.5 T and 3 T [168]. These techniques are
conceptually appealing because they allow flow measure-
ments to be made in any plane after the patient has left
the magnet. Potentially, if the scans can be accelerated,
this could be important for evaluating complicated con-
genital heart disease. The results of this study show that
although the accuracy of 4D flow is comparably good at
1.5 and 3 T the acceleration methods both resulted in an
underestimation of velocity. For flow visualisation, how-
ever, all methods produced similar quality.
Accelerating global left-ventricular function assessment
in mice using reduced slice acquisition and
three-dimensional guide-point modelling
There is a general problem of long acquisition and ana-
lysis times for measurement of cardiac function in
mouse models. In this study guide-point modelling was
used with reduced slice numbers reducing acquisition
times for the determination of left ventricular function
parameters in the infarcted mouse [169]. The study
tested the hypothesis that a reduced the number of slices
could be acquired and for accurate determination of leftventricular function using guide-point modelling. The
results confirmed the method allowed accurate analysis
of function in mice with relatively large infarcts using a
reduced slice protocol and that a further reduction was
possible in mice with a normal left-ventricular topology.
Rapid assessment of myocardial infarct size in rodents
using multi-slice inversion recovery late gadolinium
enhancement CMR at 9.4 T
This manuscript describes another development of
improved cardiac imaging in the small animal rodent model
[170]. In this case the authors have developed a multi-slice
inversion recovery technique produces high quality images
with excellent infarct definition in a short acquisition time.
The technique was applied to two preclinical scenarios of
an acute reperfused model of MI in rats and also mice 2 days
following non-reperfused MI. The study showed how the
technique could be adapted and optimised for the different
models for and in rats the method showed close agreement
for infarct sizing when compared to histological staining.
First-pass perfusion CMR two days after infarction predicts
severity of functional impairment six weeks later in the rat heart
The authors present a study on first-pass perfusion in a
small animal model, stating that perfusion and infarct
size may predict severity of impairment [171]. Perfusion
imaging in the rapidly beating rodent heart is challen-
ging and this study tackles some of the issues. A ‘novel’
and ‘simple’ perfusion method is introduced by acquiring
a 64 × 64 pixels image and zero filling k-space to a
256 × 256. The study showed that the perfusion delay was
larger in rat hearts that went on to develop greater func-
tional impairment, demonstrating that first-pass CMR
can be used as an early indicator of infarct severity.
Myocardial tagging by Cardiovascular Magnetic
Resonance: evolution of techniques--pulse sequences,
analysis algorithms, and applications
This excellent well referenced review describes in an
extremely thorough way all the tagging sequences, their
advances and how the different approaches interrelate
primarily from a technical perspective but also with an
interesting historical context [172]. The figures explain-
ing the techniques are also of high quality and helpful
for understanding. In a similar way the work also details
and compares the various methods of tagging analysis.
This is very much a technical review and clinical appli-
cations and results await future review.
Acceleration of tissue phase mapping by k-t BLAST: a
detailed analysis of the influence of k-t-BLAST for the
quantification of myocardial motion at 3 T
This manuscript describes a systematic study of the
impact of k-t BLAST on the measurement on
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Myocardial velocity measurements were compared with
every acceleration factor between 2 and 7. Interestingly
the results indicate that even with an acceleration of as
little as two there is a marginal, but statistically signifi-
cant deterioration of the velocity peaks and this is
increased with further acceleration. The temporal behav-
iour of the motion, however, was well maintained up to
an acceleration factor of six.
Varia
There is a well recognised source of referrals which is
simply put as unusual pathology, or cases where other
imaging has failed to yield a definitive diagnosis. These
include for example pericardial disease, tumours [174],
and inflammatory diseases. We therefore include this
section on papers and also include official reports,
guidelines and President's Pages [175,176] which are not
readily categorized.
Magnetic resonance imaging in patients with cardiac
pacemakers: era of "MR Conditional" designs
Advances in cardiac device technology have led to the first
generation of MR conditional devices. This timely paper
reviews the current state of the art, the likely future of
new devices and the problems in development [177].
Impact of an abdominal belt on breathing patterns and scan
efficiency in whole-heart coronary magnetic resonance
angiography: comparison between the UK and Japan
Long acquisition times and complex breathing patterns
limit the clinical applicability of whole heart 3D coron-
ary MR angiography. Ishida et al designed and tested a
tight abdominal belt in 15 Japanese and 15 English
patients, to determine whether the belt could improve
diaphragmatic position [178]. The authors showed that
scan efficiency was significantly improved in both
cohorts suggesting possible clinical utility.
Cardiovascular magnetic resonance activity in the United
Kingdom: a survey on behalf of the British society
of cardiovascular magnetic resonance
Antony et al conducted a survey of 60 National Health
Service providers of CMR in the UK and obtained
replies from 88% [179]. There were equal numbers of
cardiologists and radiologists in leadership positions.
Scan volumes had increased by 44% over the previous
2 years. The commonest indication for CMR was heart
failure and cardiomyopathy (39%) followed by coronary
artery disease and congenital disease. Formal training
programs existed in about half of centres. This survey
shows that CMR is increasing rapidly in the UK and is
well disseminated, although there are some very large
volume specialist centres.Gender differences in response to cold pressor test
assessed with velocity-encoded cardiovascular magnetic
resonance of the coronary sinus
Moro et al measured coronary sinus flow during cold
pressor stress to determine whether gender differences
could be found reflecting coronary endothelial function
[180]. The authors studied 12 normal men and 12
women at 3 T and showed that despite similar baseline
coronary sinus flow, that women increased flow signifi-
cantly more than men with stress. This test might prove
useful for assessing coronary endothelial function.
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